University of Wisconsin
School of Medicine and Public Health

Asthma: UW Research and You

The University of Wisconsin Asthma, Allergy, and Pulmonary Research team is nationally known. We have studied asthma for over 30 years and have conducted over 400 research studies with children and adults.

To learn more about participating in a clinical trial, call us at 608-263-0524 or fill out our study intake form.

Follow us on Facebook:
Facebook icon

COVID Vaccine Studies

Recruitment Flyer

Study Contact Information

For more information, see study flyer

Phone: 608-263-6049

Email: asthmaresearch@medicine.wisc.edu

Children's Studies

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness Study (ORBEX) - 5 to 16 months old

A research study in which infants (5 to 16 month olds) with a history of eczema or a parent with physician-diagnosed asthma are given a daily capsule of the investigational medication Broncho-Vaxom® (a mixture of bacteria products) to see if it helps prevent development of wheezing illness or asthma.

Current Studies:

Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness Study (ORBEX)

For more information, please contact us at pediatricasthma@medicine.wisc.edu, or call us at (608) 263-3360 or toll free (866) WIS-CARE.

Or contact us via our online webform

Inner City Asthma consortium (ICAC)

In 2002, the National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIAID) created the Inner City Asthma Consortium (ICAC). ICAC is a multi-study, multi-center initiative to study the causes of the urban asthma epidemic that afflicts millions of children and to develop treatments to improve control of asthma in this population and for children in general. UW-Madison currently provides scientific direction and overall ICAC management services. UW-Madison staff in the Departments of Medicine and Pediatrics deliver technical support involving pulmonary function testing, laboratory sample processing, contracting, procurement and budgetary matters. ICAC is composed of the UW-Madison based Administrative Center, eleven clinical sites located in major U.S. cities, four basic science laboratories, including one at the UW-Madison, and a Statistical and Clinical Coordinating Center.

Read more.

For more information, please contact us at khernand@medicine.wisc.edu.

PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma

PrecISE, the Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network, is a research study to understand how to treat different types of severe asthma. This study is currently recruiting people age 12 or older who experience asthma attacks or frequent asthma symptoms. Participants in the study will receive one or more study medicines for their severe asthma, in addition to their regularly prescribed asthma controller medication(s). Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16 week washout.

This study is sponsored by the U.S. National Heart, Lung, and Blood Institute (NHLBI). For more information about PrecISE or to see if you qualify, call us at 608-263-0524 or email us at pulm-research@medicine.wisc.edu.

Find out more!

For more information, please see the consent form or fill out this questionnaire.

CANOE: Childhood Allergy and the NeOnatal Environment

CANOE is recruiting expectant mothers for a research study to determine how early-life environmental factors cause childhood asthma and allergies. Previous birth cohort studies have found that early-life environmental factors, such as allergies, pollutants, viruses and bacteria, contribute to the development of asthma and allergies. We are doing this research because there continues to be a strong need to understand the causes of asthma and allergies. 

Find out more!

For more information, please contact us at canoe@medicine.wisc.edu

SUNBEAM: Systems Biology of Early Atopy

The goal of the SUNBEAM study is to learn more about factors that put very young children at higher risk for food allergies and eczema. This study will focus on risk factors that may be present before, during, and after birth and through the age of 3 years.

Find out more!

For more information, please contact us at sunbeam@medicine.wisc.edu

Adult Studies

PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma

PrecISE, the Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network, is a research study to understand how to treat different types of severe asthma. This study is currently recruiting people age 12 or older who experience asthma attacks or frequent asthma symptoms. Participants in the study will receive one or more study medicines for their severe asthma, in addition to their regularly prescribed asthma controller medication(s). Interventions are administered in a crossover manner with 16-week treatment periods followed by 8 to 16 week washout.

This study is sponsored by the U.S. National Heart, Lung, and Blood Institute (NHLBI). For more information about PrecISE or to see if you qualify, call us at 608-263-0524 or email us at pulm-research@medicine.wisc.edu.

Find out more!

For more information please see the consent form or fill out this questionnaire.

Pulmonary and Asthma Research PPG Blood Draw Study

Function of the Isolated Eosinophil in Asthma

The purpose of this study is to study how eosinophils contribute to airway irritation and changes in asthma.

For more information, please see the consent form.


Contact Us

If you are interested in this study, please contact us:

 pulm-research@medicine.wisc.edu

(608) 263-0524

Or fill out this questionnaire